Seed and early stage investments in exceptional technology and life sciences companies.


Redalpine news

Ebuzzing and Teads merge with an eye to join the Nasdaq in 2015 (26/03/2014)
Ebuzzing, a Redalpine Capital I portfolio company and one of the fastest growing online video technology companies globally, joins forces with Teads, a video supply-side platform, to become a global leader in video advertising. The group aims for a NASDAQ IPO in 2015. Please visit for the full press release.   · Ebuzzing and [...] More.

TrekkSoft partners with Hotelplan Suisse (26/03/2014)
TrekkSoft partners with Hotelplan Suisse to bring effective channel management of live inventory to the tour & activity segment. TrekkSoft’s distribution partnership with Hotelplan Suisse makes channel management for tour and activity companies a reality. The initial pilot phase, beginning with and followed by, will serve passengers the option to book in-destination activities [...] More.

InSphero and Biognosys continue on their growth path with new patents and products (11/03/2014)
Redalpine Capital I portfolio companies InSphero and Biognosys have been subject of promising recent developments regarding the sustainable growth of their respective businesses. InSphero was granted full patent protection for its GravityPLUS technology this January by the Patent Office of the People’s Republic of China and the Japan Patent Office. Dr. Jan Lichtenberg, CEO of [...] More.

More More Redalpine news

Industry news

What investors say

"To evaluate the potential of a new idea requires experience and a clear understanding of the products and market dynamics. We trust in the team of Redalpine to master this challenge successfully."
Jürg Staub, General Partner, Reichmuth & Co, Privatbankiers
"Switzerland's future standard of living will largely depend on its ability to remain a player at the top of technological progress. Too many revolutionary ideas of our top universities have to emigrate to Silicon Valley to find early stage venture capital or remain in the drawers. Redalpine is active in this early stage where the need is most urgent and the potential gain the highest."
Dr. Henri B. Meier, former CFO Roche, Founder of HBM BioVentures

More More investor quotes

Connect with us

Subscribe to our news

Find us on Facebook

Find us on Twitter

Find us on LinkedIn